Proteinuria in adults with sickle-cell disease: the role of hydroxycarbamide(hydroxyurea) as a protective agent

[1]  T. H. Sasongko,et al.  Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease. , 2015, The Cochrane database of systematic reviews.

[2]  A. Seguro,et al.  Renal Tubular Dysfunction in Sickle Cell Disease , 2014, Kidney and Blood Pressure Research.

[3]  R. Ware,et al.  Hydroxyurea treatment decreases glomerular hyperfiltration in children with sickle cell anemia , 2013, American journal of hematology.

[4]  F. Galactéros,et al.  Clinical management of adult sickle-cell disease , 2012, Current opinion in hematology.

[5]  G. S. Silva Júnior,et al.  New insights on pathophysiology, clinical manifestations, diagnosis, and treatment of sickle cell nephropathy , 2011, Annals of Hematology.

[6]  M. Gladwin,et al.  Sickle-cell disease , 2010, The Lancet.

[7]  A. Aleem.  Proteinuria in adult Saudi patients with sickle cell disease is not associated with identifiable risk factors. , 2010, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[8]  R. Ware.  How I use hydroxyurea to treat young patients with sickle cell anemia. , 2010, Blood.

[9]  J. Panepinto,et al.  Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities , 2010, Expert review of hematology.

[10]  C. Lobo.  Sickle cell disease - a serious problem for public health worldwide , 2010 .

[11]  Y. Amoateng-Adjepong,et al.  Complications associated with sickle cell trait: a brief narrative review. , 2009, The American journal of medicine.

[12]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[13]  A. E. El Nahas,et al.  Cardiorenal Risk Prevalence in Sickle Cell Hemoglobinopathy , 2009, Nephron Clinical Practice.

[14]  B. Pollock,et al.  National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. , 2008, Annals of internal medicine.

[15]  O. Alvarez,et al.  Short‐term follow‐up of patients with sickle cell disease and albuminuria , 2008, Pediatric blood & cancer.

[16]  I. Hambleton,et al.  Comment on: Loureiro & Rozenfeld "Epidemiology of sickle cell disease hospital admissions in Brazil". , 2006, Revista de saude publica.

[17]  Suely Rozenfeld,et al.  Epidemiologia de internações por doença falciforme no Brasil , 2005 .

[18]  R. Ware,et al.  Enalapril and hydroxyurea therapy for children with sickle nephropathy , 2005, Pediatric blood & cancer.

[19]  M. Loureiro,et al.  [Epidemiology of sickle cell disease hospital admissions in Brazil]. , 2005, Revista de saude publica.

[20]  J. M. Kauffmann,et al.  Clinical Aspects of Sickle-Cell Anaemia. , 1963 .

[21]  A. P. Crosley,et al.  Renal function in sickle cell anemia. A case report and review of the literature. , 1961, Journal of the National Medical Association.

[22]  H. Itano,et al.  Hyposthenuria in sickle cell anemia: a reversible renal defect. , 1956, The Journal of clinical investigation.